What is Invitae Corporation (NVTA)?

Invitae Corporation (NVTA) is a stock in the Healthcare sector, Medical - Diagnostics & Research industry. View full analysis on Stocks360.

What is the current price of NVTA?

The current price of NVTA is $0.02. Prices are updated in real time on Stocks360.

What is NVTA's price-to-earnings (PE) ratio?

NVTA's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is NVTA's market capitalization?

NVTA's market capitalization is $5,443,367.00, placing it in the small-cap tier.

Invitae Corporation (NVTA)

Stock analysis · NYSE · Healthcare · Medical - Diagnostics & Research

$0.02

Market Cap

$5.44M

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.59

Day Range

$0.02 – $0.02

52-wk Range

$0.02 – $2.34

Avg Volume

N/A

Volume

22.46M

Invitae Corporation (NVTA) is a publicly traded company in the Healthcare sector. Latest price: $0.02. Market cap $5.44M. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Feb 27, 2024

EPS $-0.34 vs est. $-0.30

Missed by $0.04

Proprietary Signals

Signal snapshot temporarily unavailable.

About Invitae Corporation

Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.01×
P/B	0.04×
PEG	0.00×
P/FCF (TTM)	-0.01×
EV / EBITDA	-0.52×
EV / Sales	2.90×
Earnings Yield	-69370.28%
Free Cash Flow Yield	-10035.52%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$1.50B
Revenue (TTM)	$516.30M
Net Income (TTM)	-$3.78B
Free Cash Flow (TTM)	-$490.33M
Net Debt	$1.49B
Working Capital	$585.04M
Gross Margin	19.18%
Operating Margin	-138.34%
Net Margin	-601.64%
Return on Equity	-201.69%
Return on Invested Capital	-37.74%